CRISPR Therapeutics (CRSP) PT Raised to $56 at Bernstein SocGen Group
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $54.36 --0%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 5
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 4 | New: 5
Join SI Premium – FREE
Bernstein SocGen Group analyst William Pickering raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $56.00 (from $50.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Morgan Stanley Upgrades QIAGEN NV (QIA:GR) (QGEN) to Overweight
- Volkswagen AG (VOW:GR) (VWAGY) PT Lowered to EUR94 at Citi
- Coloplast A/S (COLOB:DC) (CLPBY) PT Lowered to DKK345 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
